We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
A majority of cancer cells displayed moderate to strong cytoplasmic immunoreactivity. Gliomas, lymphomas and hepatocellular carcinomas along with most cases of skin, testicular and renal cancers were weakly stained or negative.
A majority of cancer cells displayed moderate to strong cytoplasmic staining. Additional membranous positivity was observed in several cases. Most cases of liver, renal and colorectal cancers were weakly stained or negative.
GENE INFORMATION
Gene name
LARS (HGNC Symbol)
Synonyms
FLJ10595, FLJ21788, HSPC192, LARS1, LEUS, RNTLS
Description
Leucyl-tRNA synthetase (HGNC Symbol)
Entrez gene summary
This gene encodes a cytosolic leucine-tRNA synthetase, a member of the class I aminoacyl-tRNA synthetase family. The encoded enzyme catalyzes the ATP-dependent ligation of L-leucine to tRNA(Leu). It is found in the cytoplasm as part of a multisynthetase complex and interacts with the arginine tRNA synthetase through its C-terminal domain. Alternatively spliced transcript variants of this gene have been found; however, their full-length nature is not known. [provided by RefSeq, Jul 2008]
Enzymes ENZYME proteins Ligase Predicted intracellular proteins Plasma proteins Disease related genes Potential drug targets Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Enzymes ENZYME proteins Ligase SPOCTOPUS predicted membrane proteins Predicted intracellular proteins Plasma proteins Disease related genes Potential drug targets Protein evidence (Ezkurdia et al 2014)
Enzymes ENZYME proteins Ligase Predicted intracellular proteins Plasma proteins Disease related genes Potential drug targets Protein evidence (Ezkurdia et al 2014)